|
General Information
|
|
|
Product
|
SERHL Antibody Antigenic Blocking Peptide
|
|
Description
|
Antigenic Blocking Peptide Serine hydrolase-like protein 2 isoform a Antibody Mid-Region
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Immunogen
|
Synthetic peptide
|
|
Accession #
|
NCBI: NP_055324.2
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
Mid-Region
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Western Blot
|
1:500
|
|
Protein
|
|
Uniprot #
|
Q9H4I8
|
|
Overview
|
Probable serine hydrolase. May be related to cell muscle hypertrophy.
|
|
Molecular Function
|
Hydrolase activity
|
|
Subcellular Location
|
Cytoplasm, perinuclear region; peroxisome. (Note: Concentrated in perinuclear vesicles. May be located in peroxisomes)
|
|
Alternative Nomenclature
|
BK126B4.1 antibody
BK126B4.2 antibody
HS126B42 antibody
serine hyrdolase 1 antibody
|
|
|
|
SERHL Antibody FITC
SERHL Antibody BIOTIN
SERHL Blocking Peptide
SERHL Positive Control
